Average Co-Inventor Count = 2.67
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurogen Corporation (53 from 305 patents)
2. Allergan, Inc. (4 from 2,285 patents)
3. Irm LLC (4 from 151 patents)
4. Eli Lilly and Company (2 from 4,449 patents)
5. Novartis Ag (2 from 3,923 patents)
6. Irm LLC, a Delware Limited Corporation (1 from 1 patent)
7. Pfizer Corporation (4,456 patents)
65 patents:
1. 8637516 - Compounds and compositions as TRK inhibitors
2. 8507488 - Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
3. 8202876 - Compounds and compositions as protein kinase inhibitors
4. 8101608 - Compounds and compositions as protein kinase inhibitors
5. 8026243 - [4,5']Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors
6. 7745437 - Compounds and compositions as protein kinase inhibitors
7. 7642267 - Benzimidazole and pyridylimidazole derivatives
8. 7625932 - Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
9. 7405305 - Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors
10. 7371752 - Aryl fused substituted 4-oxy-pyridines
11. 7326709 - Bicyclic and tricyclic heteroaromatic compounds
12. 7300945 - Benzimidazole and pyridylimidazole derivatives
13. 7109351 - Fused pyrrolecarboxamides; GABA brain receptor ligands
14. 7060451 - Methods for screening GABA-modulatory compounds for specified pharmacological activities
15. 7053093 - Bicyclic and tricyclic hetroaromatic compounds